Open original FDA record ↗Recall record
- FDA identifier
- Z-2346-2012
- Company in FDA record
- Hospira, Inc.
- FDA classification date
- Sep 10, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Reports of leaking during filling and administration.
Source facts
- Action
- Hospira sent an Urgent Device Field Correction letter dated August 3, 2012, to all affected customers. The letter identifed the product, the probem, and the action to be taken by the customer. Customers were instructed to first consider the use of Prefilled Morphine PCA Vials wherever possible. In some instances, the treating physician may require an alternative to morphine. Customers may continue using the affected product by following the instructions provided in the Correction Letter. Customers were asked to complete the attached Reply Form and fax it to 1-888-879-8144. For questions regarding this recall call 877-946-7747.
- Initiated
- 2012-08-02
- Root cause
- Nonconforming Material/Component
- Terminated
- 2014-05-08
- Distribution
- Worldwide Distribution - USA including AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NY, NC, NK, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WY and the countries of Canada, Costa Rica and the Virgin Islands.
- Recall number
- Z-2346-2012
- Recall status
- Terminated
- CDRH record ID
- 112021
- FDA classified
- 2012-09-10
- Recall event number
- 62909